Zobrazeno 1 - 10
of 182
pro vyhledávání: '"Richard W, Franck"'
Autor:
Mark J. Smyth, Michael H. Kershaw, Hideo Yagita, Kazuyoshi Takeda, Gurdyal S. Besra, Steven A. Porcelli, Richard W. Franck, Moriya Tsuji, Janelle Sharkey, Phillip K. Darcy, Jennifer A. Westwood, Michele W.L. Teng
Supplementary Figure 5 from Combined Natural Killer T-Cell–Based Immunotherapy Eradicates Established Tumors in Mice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a41361614f73756cf133acb451834583
https://doi.org/10.1158/0008-5472.22367721
https://doi.org/10.1158/0008-5472.22367721
Autor:
Mark J. Smyth, Michael H. Kershaw, Hideo Yagita, Kazuyoshi Takeda, Gurdyal S. Besra, Steven A. Porcelli, Richard W. Franck, Moriya Tsuji, Janelle Sharkey, Phillip K. Darcy, Jennifer A. Westwood, Michele W.L. Teng
Supplementary Legends 1-5, Table 1, Methods from Combined Natural Killer T-Cell–Based Immunotherapy Eradicates Established Tumors in Mice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87acc7f8e6b5b77362da4de44fc803b5
https://doi.org/10.1158/0008-5472.22367718.v1
https://doi.org/10.1158/0008-5472.22367718.v1
Autor:
Mark J. Smyth, Michael H. Kershaw, Hideo Yagita, Kazuyoshi Takeda, Gurdyal S. Besra, Steven A. Porcelli, Richard W. Franck, Moriya Tsuji, Janelle Sharkey, Phillip K. Darcy, Jennifer A. Westwood, Michele W.L. Teng
Supplementary Figure 3 from Combined Natural Killer T-Cell–Based Immunotherapy Eradicates Established Tumors in Mice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bb6ab05afb12d5198c3826a8a8c53b3
https://doi.org/10.1158/0008-5472.22367727.v1
https://doi.org/10.1158/0008-5472.22367727.v1
Autor:
Mark J. Smyth, Michael H. Kershaw, Hideo Yagita, Kazuyoshi Takeda, Gurdyal S. Besra, Steven A. Porcelli, Richard W. Franck, Moriya Tsuji, Janelle Sharkey, Phillip K. Darcy, Jennifer A. Westwood, Michele W.L. Teng
A rational monoclonal antibody (mAb)-based antitumor therapy approach has previously been shown to eradicate various established experimental and carcinogen-induced tumors in a majority of mice. This therapy comprised an agonistic mAb reactive with t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5382012d77c1e12a700a7e65a859586c
https://doi.org/10.1158/0008-5472.c.6495660
https://doi.org/10.1158/0008-5472.c.6495660
Autor:
Mark J. Smyth, Michael H. Kershaw, Hideo Yagita, Kazuyoshi Takeda, Gurdyal S. Besra, Steven A. Porcelli, Richard W. Franck, Moriya Tsuji, Janelle Sharkey, Phillip K. Darcy, Jennifer A. Westwood, Michele W.L. Teng
Supplementary Figure 1 from Combined Natural Killer T-Cell–Based Immunotherapy Eradicates Established Tumors in Mice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eae3521a7b22f889e10799e080696c7
https://doi.org/10.1158/0008-5472.22367733.v1
https://doi.org/10.1158/0008-5472.22367733.v1
Autor:
Mark J. Smyth, Michael H. Kershaw, Hideo Yagita, Kazuyoshi Takeda, Gurdyal S. Besra, Steven A. Porcelli, Richard W. Franck, Moriya Tsuji, Janelle Sharkey, Phillip K. Darcy, Jennifer A. Westwood, Michele W.L. Teng
Supplementary Figure 4 from Combined Natural Killer T-Cell–Based Immunotherapy Eradicates Established Tumors in Mice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47d1e6a10c0d554baffc72663aced0fe
https://doi.org/10.1158/0008-5472.22367724.v1
https://doi.org/10.1158/0008-5472.22367724.v1
Autor:
Mark J. Smyth, Michael H. Kershaw, Hideo Yagita, Kazuyoshi Takeda, Gurdyal S. Besra, Steven A. Porcelli, Richard W. Franck, Moriya Tsuji, Janelle Sharkey, Phillip K. Darcy, Jennifer A. Westwood, Michele W.L. Teng
Supplementary Figure 2 from Combined Natural Killer T-Cell–Based Immunotherapy Eradicates Established Tumors in Mice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23391379169fbe8cd049ff4c3d15fd04
https://doi.org/10.1158/0008-5472.22367730.v1
https://doi.org/10.1158/0008-5472.22367730.v1
Publikováno v:
Chemistry - A European Journal. 23:1728-1742
In this review, we discuss small-molecule, carbohydrate-based immunostimulants that target Toll-like receptor 4 (TLR-4) and cluster of differentiation 1D (CD1d) receptors. The design and use of these molecules in immunotherapy as well as results from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c99b72fe799c727836f5753890c988f
https://doi.org/10.1002/chem.201601539
https://doi.org/10.1002/chem.201601539
Autor:
Sampada Chitale, Esther Dawen Yu, Amy R. Howell, Richard W. Franck, Marek Nemčovič, Moriya Tsuji, Dirk M. Zajonc, Mitchell Kronenberg, Serge Van Calenbergh, Jing Wang, Archana Khurana, Enrico Girardi, Nora Pauwels, Elisa Farber, Alysia Birkholz
Publikováno v:
JOURNAL OF BIOLOGICAL CHEMISTRY
The ability of different glycosphingolipids (GSLs) to activate type I natural killer T cells (NKT cells) has been known for 2 decades. The possible therapeutic use of these GSLs has been studied in many ways; however, studies are needed in which the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db7a67358a35340db7585f153e94736f
https://doi.org/10.1074/jbc.m115.654814
https://doi.org/10.1074/jbc.m115.654814
The identification of immunoactive agents for clinical and mechanistic applications is a very active area of research. In this vein, analogues of the potent immunostimulant KRN 7000 with diverse cytokine profiles have attracted considerable attention
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07cd706292357afeffe2d4c5d35464b4
https://europepmc.org/articles/PMC5499692/
https://europepmc.org/articles/PMC5499692/